See also:

• HIV/AIDS
• News & reports, international standards and introductory material
• Positive steps by companies

 ________________________________________________________________________________

• [DOC] “Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines – draft for consultation”
  - Author and date: Paul Hunt, then UN Special Rapporteur on the Right to Health, 19 Sep 2007
  - Commentaries on the draft Guidelines

• [PDF] “Human rights guidelines for pharmaceutical companies in relation to access to medicines: The sexual and reproductive health context”
  - Author and date: Rajat Khosla & Paul Hunt, Human Rights Centre, University of Essex, 2009

• [PDF] “Investing for Life – Meeting poor people’s needs for access to medicines through responsible business practices”
  - Oxfam Intl. briefing paper, Nov 2007

• Pharma Futures
  - Description: "...an investor-led dialogue that explores how to better align corporate profitability with improved access to innovative and affordable healthcare"

• Access to Medicine Index
  - Author: Access to Medicine Foundation
  - (New methodology to be published in 2010)

Material by companies:

• GlaxoSmithKline: [PDF] "Public Policy Issues - GlaxoSmithKline’s Position - Intellectual Property & Access to Medicines in Developing Countries"

• Novartis Foundation: [PDF] "Corporate responsibilties for access to medicines"
  - Author and date: Klaus Leisinger, 2008